The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients.
D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000209:etiology; D001519:Behavior / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000209:etiology; D010300:Parkinson Disease / Q000209:etiology; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome; D013881:Thioridazine / Q000627:therapeutic use; D014202:Tremor / Q000209:etiology
D000978:Antiparkinson Agents; D013881:Thioridazine; D002746:Chlorpromazine